The Genetic Basis of Peripheral Arterial Disease: Current Knowledge, Challenges, and Future Directions

Circulation Research

Volumn 116, Issue 9, 2015, Pages 1551-1560

  Kullo, Iftikhar J ^a   Leeper, Nicholas J ^b  

^a MAYO CLINIC   (United States)

^b Centers for Health Policy and Primary Care and Outcomes Research   (United States)

Author keywords

epigenomics; genome wide association study; molecular epidemiology; peripheral arterial disease

Indexed keywords

ARTICLE; DIABETES MELLITUS; DYSLIPIDEMIA; EPIGENETICS; ETHNIC DIFFERENCE; FAMILY HISTORY; GENE EXPRESSION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEREDITY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MICROBIOME; ONSET AGE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PLEIOTROPY; PRIORITY JOURNAL; RNA SEQUENCE; FORECASTING; GENE EXPRESSION PROFILING; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; HIGH THROUGHPUT SEQUENCING; PROCEDURES; SINGLE NUCLEOTIDE POLYMORPHISM; TRENDS;

EPIGENESIS, GENETIC; FORECASTING; GENE EXPRESSION PROFILING; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; PERIPHERAL ARTERIAL DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84942890179     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.303518     Document Type: Article

References (113)

1. Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, Norman PE, Sampson UK, Williams LJ, Mensah GA, Criqui MH. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382:1329-1340. doi: 10.1016/S0140-6736(13)61249-0.
2. Allison MA, Ho E, Denenberg JO, Langer RD, Newman AB, Fabsitz RR, Criqui MH. Ethnic-specific prevalence of peripheral arterial disease in the United States. Am J Prev Med. 2007;32:328-333. doi: 10.1016/j. amepre.2006.12.010.
3. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. 2004;110:738-743.
4. Golomb BA, Dang TT, Criqui MH. Peripheral arterial disease: morbidity and mortality implications. Circulation. 2006;114:688-699. doi: 10.1161/ CIRCULATIONAHA.105.593442.
5. Mahoney EM, Wang K, Cohen DJ, Hirsch AT, Alberts MJ, Eagle K, Mosse F, Jackson JD, Steg PG, Bhatt DL; REACH Registry Investigators. Oneyear costs in patients with a history of or at risk for atherothrombosis in the United States. Circ Cardiovasc Qual Outcomes. 2008;1:38-45. doi: 10.1161/CIRCOUTCOMES.108.775247.
6. Hirsch AT, Hartman L, Town RJ, Virnig BA. National health care costs of peripheral arterial disease in the Medicare population. Vasc Med. 2008;13:209-215. doi: 10.1177/1358863X08089277.
7. Iglehart JK. Prioritizing comparative-effectiveness research-IOM recommendations. N Engl J Med. 2009;361:325-328. doi: 10.1056/ NEJMp0904133.
8. Grenon SM, Gagnon J, Hsiang Y. Video in clinical medicine. Anklebrachial index for assessment of peripheral arterial disease. N Engl J Med. 2009;361:e40. doi: 10.1056/NEJMvcm0807012.
9. Carter SA. Indirect systolic pressures and pulse waves in arterial occlusive diseases of the lower extremities. Circulation. 1968;37:624-637.
10. Kiekara O, Riekkinen H, Soimakallio S, Länsimies E. Correlation of angiographically determined reduction of vascular lumen with lower-limb systolic pressures. Acta Chir Scand. 1985;151:437-440.
11. Arain FA, Ye Z, Bailey KR, Chen Q, Liu G, Leibson CL, Kullo IJ. Survival in patients with poorly compressible leg arteries. J Am Coll Cardiol. 2012;59:400-407. doi: 10.1016/j.jacc.2011.09.055.
12. Leeper NJ, Kullo IJ, Cooke JP. Genetics of peripheral artery disease. Circulation. 2012;125:3220-3228. doi: 10.1161/ CIRCULATIONAHA.111.033878.
13. Downing KP, Nead KT, Kojima Y, Assimes T, Maegdefessel L, Quertermous T, Cooke JP, Leeper NJ. The combination of 9p21.3 genotype and biomarker profile improves a peripheral artery disease risk prediction model. Vasc Med. 2014;19:3-8. doi: 10.1177/1358863X13514791.
14. Deloukas P, Kanoni S, Willenborg C, et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 2013;45:25-33. doi: 10.1038/ng.2480.
15. Chang P, Nead KT, Olin JW, Cooke JP, Leeper NJ. Clinical and socioeconomic factors associated with unrecognized peripheral artery disease. Vasc Med. 2014;19:289-296. doi: 10.1177/1358863X14535475.
16. Kullo IJ, Bailey KR, Kardia SL, Mosley TH Jr, Boerwinkle E, Turner ST. Ethnic differences in peripheral arterial disease in the NHLBI Genetic Epidemiology Network of Arteriopathy (GENOA) study. Vasc Med. 2003;8:237-242.
17. Newman AB, Sutton-Tyrrell K, Vogt MT, Kuller LH. Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. JAMA. 1993;270:487-489.
18. Kuller L, Fisher L, McClelland R, Fried L, Cushman M, Jackson S, Manolio T. Differences in prevalence of and risk factors for subclinical vascular disease among black and white participants in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 1998;18:283-293.
19. Collins TC, Johnson M, Henderson W, Khuri SF, Daley J. Lower extremity nontraumatic amputation among veterans with peripheral arterial disease: is race an independent factor? Med Care. 2002;40:I106-I116.
20. Freedman DS, Newman WP III, Tracy RE, Voors AE, Srinivasan SR, Webber LS, Restrepo C, Strong JP, Berenson GS. Black-white differences in aortic fatty streaks in adolescence and early adulthood: the Bogalusa Heart Study. Circulation. 1988;77:856-864.
21. Singh S, Bailey KR, Kullo IJ. Ethnic differences in ankle brachial index are present in middle-aged individuals without peripheral arterial disease. Int J Cardiol. 2013;162:228-233. doi: 10.1016/j.ijcard.2011.05.068.
22. Valdez R, Yoon PW, Qureshi N, Green RF, Khoury MJ. Family history in public health practice: a genomic tool for disease prevention and health promotion∗. Ann Rev of Publ Health. 2010;31:69-87. doi: 10.1146/annurev. publhealth.012809.103621.
23. Guttmacher AE, Collins FS, Carmona RH. The family history-more important than ever. N Engl J Med. 2004;351:2333-2336. doi: 10.1056/ NEJMsb042979.
24. Hirsch AT, Haskal ZJ, Hertzer NR, et al; American Association for Vascular Surgery; Society for Vascular Surgery; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society of Interventional Radiology; ACC/AHA Task Force on Practice Guidelines Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease; American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; Vascular Disease Foundation. ACC/AHA Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic). Circulation. 2006;113:e463-654. doi: 10.1161/CIRCULATIONAHA.106.174526.
25. Wahlgren CM, Magnusson PK. Genetic influences on peripheral arterial disease in a twin population. Arterioscler Thromb Vasc Biol. 2011;31:678-682. doi: 10.1161/ATVBAHA.110.210385.
26. Wassel CL, Loomba R, Ix JH, Allison MA, Denenberg JO, Criqui MH. Family history of peripheral artery disease is associated with prevalence and severity of peripheral artery disease: the San Diego population study. J Am Coll Cardiol. 2011;58:1386-1392. doi: 10.1016/j. jacc.2011.06.023.
27. Khaleghi M, Isseh IN, Bailey KR, Kullo IJ. Family history as a risk factor for peripheral arterial disease. Am J Cardiol. 2014;114:928-932. doi: 10.1016/j.amjcard.2014.06.029.
28. Barretto S, Ballman KV, Rooke TW, Kullo IJ. Early-onset peripheral arterial occlusive disease: clinical features and determinants of disease severity and location. Vasc Med. 2003;8:95-100.
29. Valentine RJ, MacGillivray DC, DeNobile JW, Snyder DA, Rich NM. Intermittent claudication caused by atherosclerosis in patients aged forty years and younger. Surgery. 1990;107:560-565.
30. Levy PJ, Gonzalez MF, Hornung CA, Chang WW, Haynes JL, Rush DS. A prospective evaluation of atherosclerotic risk factors and hypercoagulability in young adults with premature lower extremity atherosclerosis. J Vasc Surg. 1996;23:36-43; discussion 43.
31. Nitter-Hauge S, Erikssen J, Thaulow E, Vatne K. Angiographic and risk factor characteristics of subjects with early onset ischaemic heart disease. Br Heart J. 1981;46:325-330.
32. Hutter CM, Austin MA, Humphries SE. Familial hypercholesterolemia, peripheral arterial disease, and stroke: a HuGE minireview. Am J Epidemiol. 2004;160:430-435. doi: 10.1093/aje/kwh238.
33. Johnston JD. A case of heterozygous familial hypercholesterolaemia who developed exclusive peripheral vascular disease. Ann Clin Biochem. 1997;34 (pt 3):321-323.
34. Vitale E, Zuliani G, Baroni L, Bicego L, Grego F, Valerio G, Fellin R. Lipoprotein abnormalities in patients with extra-coronary arteriosclerosis. Atherosclerosis. 1990;81:95-102.
35. Boers GH, Smals AG, Trijbels FJ, Fowler B, Bakkeren JA, Schoonderwaldt HC, Kleijer WJ, Kloppenborg PW. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med. 1985;313:709-715. doi: 10.1056/NEJM198509193131201.
36. Leftheriotis G, Kauffenstein G, Hamel JF, Abraham P, Le Saux O, Willoteaux S, Henrion D, Martin L. The contribution of arterial calcification to peripheral arterial disease in pseudoxanthoma elasticum. PLoS One. 2014;9:e96003. doi: 10.1371/journal.pone.0096003.
37. Gudmundsson G, Matthiasson SE, Arason H, et al. Localization of a gene for peripheral arterial occlusive disease to chromosome 1p31. Am J Hum Genet. 2002;70:586-592. doi: 10.1086/339251.
38. Kullo IJ, Turner ST, Kardia SL, Mosley TH Jr, Boerwinkle E, de Andrade M. A genome-wide linkage scan for ankle-brachial index in African American and non-Hispanic white subjects participating in the GENOA study. Atherosclerosis. 2006;187:433-438. doi: 10.1016/j. atherosclerosis.2005.10.003.
39. Fowkes FG, Connor JM, Smith FB, Wood J, Donnan PT, Lowe GD. Fibrinogen genotype and risk of peripheral atherosclerosis. Lancet. 1992;339:693-696.
40. Monsalve MV, Young R, Jobsis J, Wiseman SA, Dhamu S, Powell JT, Greenhalgh RM, Humphries SE. DNA polymorphisms of the gene for apolipoprotein B in patients with peripheral arterial disease. Atherosclerosis. 1988;70:123-129.
41. Fowkes FG, Lee AJ, Hau CM, Cooke A, Connor JM, Lowe GD. Methylene tetrahydrofolate reductase (MTHFR) and nitric oxide synthase (ecNOS) genes and risks of peripheral arterial disease and coronary heart disease: Edinburgh Artery Study. Atherosclerosis. 2000;150:179-185.
42. Kullo IJ, Greene MT, Boerwinkle E, Chu J, Turner ST, Kardia SL. Association of polymorphisms in NOS3 with the ankle-brachial index in hypertensive adults. Atherosclerosis. 2008;196:905-912. doi: 10.1016/j. atherosclerosis.2007.02.008.
43. Morrison AC, Doris PA, Folsom AR, Nieto FJ, Boerwinkle E; Atherosclerosis Risk in Communities Study. G-protein beta3 subunit and alpha-adducin polymorphisms and risk of subclinical and clinical stroke. Stroke. 2001;32:822-829.
44. Flex A, Gaetani E, Pola R, Santoliquido A, Aloi F, Papaleo P, Dal Lago A, Pola E, Serricchio M, Tondi P, Pola P. The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with peripheral artery occlusive disease. Eur J Vasc Endovasc Surg. 2002;24:264-268.
45. Li R, Folsom AR, Sharrett AR, Couper D, Bray M, Tyroler HA. Interaction of the glutathione S-transferase genes and cigarette smoking on risk of lower extremity arterial disease: the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis. 2001;154:729-738.
46. Kardia SL, Greene MT, Boerwinkle E, Turner ST, Kullo IJ. Investigating the complex genetic architecture of ankle-brachial index, a measure of peripheral arterial disease, in non-Hispanic whites. BMC Med Genomics. 2008;1:16. doi: 10.1186/1755-8794-1-16.
47. Wassel CL, Lamina C, Nambi V, et al. Genetic determinants of the anklebrachial index: a meta-analysis of a cardiovascular candidate gene 50K SNP panel in the candidate gene association resource (CARe) consortium. Atherosclerosis. 2012;222:138-147. doi: 10.1016/j.atherosclerosis. 2012.01.039.
48. Helgadottir A, Thorleifsson G, Magnusson KP, et al. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet. 2008;40:217-224. doi: 10.1038/ng.72.
49. Thorgeirsson TE, Geller F, Sulem P, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature. 2008;452:638-642. doi: 10.1038/nature06846.
50. Gretarsdottir S, Baas AF, Thorleifsson G, et al. Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm. Nat Genet. 2010;42:692-697. doi: 10.1038/ng.622.
51. Koriyama H, Nakagami H, Katsuya T, Sugimoto K, Yamashita H, Takami Y, Maeda S, Kubo M, Takahashi A, Nakamura Y, Ogihara T, Rakugi H, Kaneda Y, Morishita R. Identification of evidence suggestive of an association with peripheral arterial disease at the OSBPL10 locus by genomewide investigation in the Japanese population. J Atheroscler Thromb. 2010;17:1054-1062.
52. Murabito JM, White CC, Kavousi M, et al. Association between chromosome 9p21 variants and the ankle-brachial index identified by a metaanalysis of 21 genome-wide association studies. Circ Cardiovasc Genet. 2012;5:100-112. doi: 10.1161/CIRCGENETICS.111.961292.
53. Harismendy O, Notani D, Song X, Rahim NG, Tanasa B, Heintzman N, Ren B, Fu XD, Topol EJ, Rosenfeld MG, Frazer KA. 9p21 DNA variants associated with coronary artery disease impair interferon-λ signalling response. Nature. 2011;470:264-268. doi: 10.1038/nature09753.
54. Visel A, Zhu Y, May D, Afzal V, Gong E, Attanasio C, Blow MJ, Cohen JC, Rubin EM, Pennacchio LA. Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature. 2010;464:409-412. doi: 10.1038/nature08801.
55. Kojima Y, Downing K, Kundu R, Miller C, Dewey F, Lancero H, Raaz U, Perisic L, Hedin U, Schadt E, Maegdefessel L, Quertermous T, Leeper NJ. Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis. J Clin Invest. 2014;124:1083-1097. doi: 10.1172/JCI70391.
56. Lyons PA, Rayner TF, Trivedi S, et al. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med. 2012;367:214-223. doi: 10.1056/NEJMoa1108735.
57. Burgner D, Davila S, Breunis WB, et al; International Kawasaki Disease Genetics Consortium. A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease. PLoS Genet. 2009;5:e1000319. doi: 10.1371/journal.pgen.1000319.
58. Khor CC, Davila S, Breunis WB, et al; Hong Kong-Shanghai Kawasaki Disease Genetics Consortium; Korean Kawasaki Disease Genetics Consortium; Taiwan Kawasaki Disease Genetics Consortium; International Kawasaki Disease Genetics Consortium; US Kawasaki Disease Genetics Consortium; Blue Mountains Eye Study. Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat Genet. 2011;43:1241-1246. doi: 10.1038/ng.981.
59. Lee YC, Kuo HC, Chang JS, et al; Taiwan Pediatric ID Alliance. Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis. Nat Genet. 2012;44:522-525. doi: 10.1038/ng.2227.
60. Onouchi Y, Ozaki K, Burns JC, et al; Japan Kawasaki Disease Genome Consortium; US Kawasaki Disease Genetics Consortium. A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet. 2012;44:517-521. doi: 10.1038/ng.2220.
61. Mizuki N, Meguro A, Ota M, et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci. Nat Genet. 2010;42:703-706. doi: 10.1038/ng.624.
62. Hou S, Yang Z, Du L, Jiang Z, Shu Q, Chen Y, Li F, Zhou Q, Ohno S, Chen R, Kijlstra A, Rosenbaum JT, Yang P. Identification of a susceptibility locus in STAT4 for Behçet's disease in Han Chinese in a genome-wide association study. Arthritis Rheum. 2012;64:4104-4113. doi: 10.1002/art.37708.
63. Lee YJ, Horie Y, Wallace GR, et al. Genome-wide association study identifies GIMAP as a novel susceptibility locus for Behcet's disease. Ann Rheum Dis. 2013;72:1510-1516. doi: 10.1136/annrheumdis-2011-200288.
64. Kirino Y, Bertsias G, Ishigatsubo Y, et al. Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B∗51 and ERAP1. Nat Genet. 2013;45:202-207. doi: 10.1038/ng.2520.
65. Kullo IJ, Shameer K, Jouni H, Lesnick TG, Pathak J, Chute CG, de Andrade M. The ATXN2-SH2B3 locus is associated with peripheral arterial disease: an electronic medical record-based genome-wide association study. Front Genet. 2014;5:166. doi: 10.3389/fgene.2014.00166.
66. Devallière J, Charreau B. The adaptor Lnk (SH2B3): an emerging regulator in vascular cells and a link between immune and inflammatory signaling. Biochem Pharmacol. 2011;82:1391-1402. doi: 10.1016/j. bcp.2011.06.023.
67. Devalliere J, Chatelais M, Fitau J, Gerard N, Hulin P, Velazquez L, Turner CE, Charreau B. LNK (SH2B3) is a key regulator of integrin signaling in endothelial cells and targets alpha-parvin to control cell adhesion and migration. FASEB J. 2012;26:2592-2606. doi: 10.1096/fj.11-193383.
68. Zhernakova A, Elbers CC, Ferwerda B, et al; Finnish Celiac Disease Study Group. Evolutionary and functional analysis of celiac risk loci reveals SH2B3 as a protective factor against bacterial infection. Am J Hum Genet. 2010;86:970-977. doi: 10.1016/j.ajhg.2010.05.004.
69. Ding K, Kullo IJ. Geographic differences in allele frequencies of susceptibility SNPs for cardiovascular disease. BMC Med Genet. 2011;12:55. doi: 10.1186/1471-2350-12-55.
70. Pickrell JK, Coop G, Novembre J, Kudaravalli S, Li JZ, Absher D, Srinivasan BS, Barsh GS, Myers RM, Feldman MW, Pritchard JK. Signals of recent positive selection in a worldwide sample of human populations. Genome Res. 2009;19:826-837. doi: 10.1101/gr.087577.108.
71. Kullo IJ, Fan J, Pathak J, Savova GK, Ali Z, Chute CG. Leveraging informatics for genetic studies: use of the electronic medical record to enable a genome-wide association study of peripheral arterial disease. J Am Med Inform Assoc. 2010;17:568-574. doi: 10.1136/jamia.2010.004366.
72. McCarty CA, Chisholm RL, Chute CG, Kullo IJ, Jarvik GP, Larson EB, Li R, Masys DR, Ritchie MD, Roden DM, Struewing JP, Wolf WA; eMERGE Team. The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med Genomics. 2011;4:13. doi: 10.1186/1755-8794-4-13.
73. Kho AN, Pacheco JA, Peissig PL, Rasmussen L, Newton KM, Weston N, Crane PK, Pathak J, Chute CG, Bielinski SJ, Kullo IJ, Li R, Manolio TA, Chisholm RL, Denny JC. Electronic medical records for genetic research: results of the eMERGE consortium. Sci Transl Med. 2011;3:79re1. doi: 10.1126/scitranslmed.3001807.
74. Chen Q, Smith CY, Bailey KR, Wennberg PW, Kullo IJ. Disease location is associated with survival in patients with peripheral arterial disease. J Am Heart Assoc. 2013;2:e000304. doi: 10.1161/JAHA.113.000304.
75. Lusis AJ, Mar R, Pajukanta P. Genetics of atherosclerosis. Annu Rev Genomics Hum Genet. 2004;5:189-218. doi: 10.1146/annurev. genom.5.061903.175930.
76. Nelson MR, Kardia SL, Ferrell RE, Sing CF. A combinatorial partitioning method to identify multilocus genotypic partitions that predict quantitative trait variation. Genome Res. 2001;11:458-470. doi: 10.1101/gr.172901.
77. St Hilaire C, Ziegler SG, Markello TC, et al. NT5E mutations and arterial calcifications. N Engl J Med. 2011;364:432-442. doi: 10.1056/ NEJMoa0912923.
78. Shameer K, Klee EW, Dalenberg AK, Kullo IJ. Whole exome sequencing implicates an INO80D mutation in a syndrome of aortic hypoplasia, premature atherosclerosis, and arterial stiffness. Circ Cardiovasc Genet. 2014;7:607-614. doi: 10.1161/CIRCGENETICS.113.000233.
79. Morrison AJ, Shen X. Chromatin remodelling beyond transcription: the INO80 and SWR1 complexes. Nat Rev Mol Cell Biol. 2009;10:373-384. doi: 10.1038/nrm2693.
80. Whitney AR, Diehn M, Popper SJ, Alizadeh AA, Boldrick JC, Relman DA, Brown PO. Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci U S A. 2003;100:1896-1901. doi: 10.1073/pnas.252784499.
81. Eady JJ, Wortley GM, Wormstone YM, Hughes JC, Astley SB, Foxall RJ, Doleman JF, Elliott RM. Variation in gene expression profiles of peripheral blood mononuclear cells from healthy volunteers. Physiol Genomics. 2005;22:402-411. doi: 10.1152/physiolgenomics.00080.2005.
82. Masud R, Shameer K, Dhar A, Ding K, Kullo IJ. Gene expression profiling of peripheral blood mononuclear cells in the setting of peripheral arterial disease. J Clin Bioinforma. 2012;2:6. doi: 10.1186/2043-9113-2-6.
83. Valentine RJ, Verstraete R, Clagett GP, Cohen JC. Premature cardiovascular disease is common in relatives of patients with premature peripheral atherosclerosis. Arch Intern Med. 2000;160:1343-1348.
84. Gschwendtner A, Bevan S, Cole JW, et al; International Stroke Genetics Consortium. Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke. Ann Neurol. 2009;65:531-539. doi: 10.1002/ ana.21590.
85. Tragante V, Doevendans PA, Nathoe HM, van der Graaf Y, Spiering W, Algra A, de Borst GJ, de Bakker PI, Asselbergs FW; SMART study group. The impact of susceptibility loci for coronary artery disease on other vascular domains and recurrence risk. Eur Heart J. 2013;34:2896-2904. doi: 10.1093/eurheartj/eht222.
86. Gudbjartsson DF, Bjornsdottir US, Halapi E, et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet. 2009;41:342-347. doi: 10.1038/ng.323.
87. Gieger C, Radhakrishnan A, Cvejic A, et al. New gene functions in megakaryopoiesis and platelet formation. Nature. 2011;480:201-208. doi: 10.1038/nature10659.
88. Shameer K, Denny JC, Ding K, et al. A genome- and phenome-wide association study to identify genetic variants influencing platelet count and volume and their pleiotropic effects. Hum Genet. 2013;133:95-109. doi: 10.1007/s00439-013-1355-7.
89. Barrett JC, Clayton DG, Concannon P, et al; Type 1 Diabetes Genetics Consortium. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet. 2009;41:703-707. doi: 10.1038/ng.381.
90. Takizawa H, Nishimura S, Takayama N, et al. Lnk regulates integrin alphaIIbbeta3 outside-in signaling in mouse platelets, leading to stabilization of thrombus development in vivo. J Clin Invest. 2010;120:179-190. doi: 10.1172/JCI39503.
91. Handy DE, Castro R, Loscalzo J. Epigenetic modifications: basic mechanisms and role in cardiovascular disease. Circulation. 2011;123:2145-2156. doi: 10.1161/CIRCULATIONAHA.110.956839.
92. Breitling LP. Current genetics and epigenetics of smoking/tobacco-related cardiovascular disease. Arterioscler Thromb Vasc Biol. 2013;33:1468-1472. doi: 10.1161/ATVBAHA.112.300157.
93. Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet. 2014;15:7-21. doi: 10.1038/ nrg3606.
94. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12:861-874. doi: 10.1038/nrg3074.
95. Peschansky VJ, Wahlestedt C. Non-coding RNAs as direct and indirect modulators of epigenetic regulation. Epigenetics. 2014;9:3-12. doi: 10.4161/epi.27473.
96. Aryal B, Rotllan N, Fernández-Hernando C. Noncoding RNAs and atherosclerosis. Curr Atheroscler Rep. 2014;16:407. doi: 10.1007/ s11883-014-0407-3.
97. Hamburg NM, Leeper NJ. Therapeutic potential of modulating microRNA in peripheral artery disease [published online ahead of print May 13, 2013]. Curr Vasc Pharmacol.
98. Caporali A, Meloni M, Völlenkle C, et al. Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia. Circulation. 2011;123:282-291. doi: 10.1161/CIRCULATIONAHA.110.952325.
99. Leeper NJ, Cooke JP. MicroRNA and mechanisms of impaired angiogenesis in diabetes mellitus. Circulation. 2011;123:236-238. doi: 10.1161/ CIRCULATIONAHA.110.003855.
100. Stather PW, Sylvius N, Wild JB, Choke E, Sayers RD, Bown MJ. Differential microRNA expression profiles in peripheral arterial disease. Circ Cardiovasc Genet. 2013;6:490-497. doi: 10.1161/CIRCGENETICS. 113.000053.
101. Kotake Y, Nakagawa T, Kitagawa K, Suzuki S, Liu N, Kitagawa M, Xiong Y. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene. 2011;30:1956-1962. doi: 10.1038/onc.2010.568.
102. Leeper NJ, Raiesdana A, Kojima Y, et al. Loss of CDKN2B promotes p53-dependent smooth muscle cell apoptosis and aneurysm formation. Arterioscler Thromb Vasc Biol. 2013;33:e1-e10. doi: 10.1161/ ATVBAHA.112.300399.
103. Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature. 2009;461:747-753. doi: 10.1038/ nature08494.
104. Cohen JC, Boerwinkle E, Mosley TH Jr, Hobbs HH. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med. 2006;354:1264-1272. doi: 10.1056/NEJMoa054013.
105. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, Henning AK, SanGiovanni JP, Mane SM, Mayne ST, Bracken MB, Ferris FL, Ott J, Barnstable C, Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308:385-389. doi: 10.1126/science.1109557.
106. Huyghe JR, Jackson AU, Fogarty MP, et al. Exome array analysis identifies new loci and low-frequency variants influencing insulin processing and secretion. Nat Genet. 2013;45:197-201. doi: 10.1038/ng.2507.
107. Wu S, Lusis AJ, Drake TA. A systems-based framework for understanding complex metabolic and cardiovascular disorders. J Lipid Res. 2009;50(suppl):S358-S363. doi: 10.1194/jlr.R800067-JLR200.
108. Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000;25:25-29. doi: 10.1038/75556.
109. Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000;28:27-30.
110. Croft D, O'Kelly G, Wu G, Haw R, Gillespie M, Matthews L, Caudy M, Garapati P, Gopinath G, Jassal B. Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res. 2010;39:D691-D697. doi: 10.1093/nar/gkq1018.
111. Koren O, Spor A, Felin J, Fåk F, Stombaugh J, Tremaroli V, Behre CJ, Knight R, Fagerberg B, Ley RE, Bäckhed F. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci U S A. 2011;108(suppl 1):4592-4598. doi: 10.1073/pnas.1011383107.
112. Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472:57-63. doi: 10.1038/nature09922.
113. Tang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, Wu Y, Hazen SL. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013;368:1575-1584. doi: 10.1056/ NEJMoa1109400.